Virios Therapeutics Inc.
13F holders, Q1 2024 (March 31)20holders
$0.48avg. 13F price*
At the end of Q1 2024, 20 institutions reported holding Virios Therapeutics Inc. in their 13F filings. The largest holders were Vanguard Group Inc. ($100K), Geode Capital Management, LLC ($84K) and State Street Corp. ($25K).
- Company
- Virios Therapeutics Inc.
- CUSIP
- 92829J104
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $34K |
| Exits | 4 | $143K |
Ownership 20 holders
| Vanguard Group Inc. | 0.00% | No change | 208,883 | $100K |
| Geode Capital Management, LLC | 0.00% | No change | 174,469 | $84K |
| State Street Corp. | 0.00% | No change | 52,828 | $25K |
| McCollum Christoferson Group LLC | 0.01% | Add +13.5% | 42,000 | $20K |
| Raymond James & Associates | 0.00% | No change | 30,000 | $14K |
| Northern Trust Corp. | 0.00% | No change | 24,035 | $12K |
| Susquehanna International Group, LLP | 0.00% | New | 23,363 | $11K |
| Regions Financial Corp. | 0.00% | No change | 20,072 | $10K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 19,062 | $9K |
| Jane Street Group, LLC | 0.00% | New | 16,998 | $8K |
| Morgan Stanley | 0.00% | No change | 15,000 | $7K |
| Cetera Investment Advisers | 0.00% | New | 12,101 | $6K |
| &partners | 0.00% | No change | 11,000 | $5K |
| William Howard & Co Financial Advisors Inc | 0.00% | — | 10,072 | $5K |
| Group One Trading LLC | 0.00% | Reduce -42.0% | 8,111 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1.6% | 6,811 | $3K |
| Cutler Group LLC / CA | 0.00% | No change | 2,300 | $1K |
| BlackRock Inc. | 0.00% | No change | 755 | $362 |
| Wells Fargo & Company | 0.00% | Add +2.3% | 133 | $64 |
| Royal Bank of Canada | 0.00% | No change | 56 | $0 |
"% of holder's portfolio" is VIRIOS THERAPEUTICS INC's weight in each manager's 13F, not the share of Virios Therapeutics Inc. the manager owns.